Feb 26, 2025BiopharmaEli Lilly Acquires Organovo’s FXR Agonist for Up to $50 Million, Sparking Stock Surge
Apr 15, 2024Biopharma2024’s Most Anticipated Drug Launches5 Medicines in Line to Storm the Market This Year With 2023 bringing 55 new drug approvals, the pharmaceutical sector is poised to...
